摘要
目的:探讨增殖诱导配体(APRIL)基因在 SW480裸鼠移植瘤中的作用。方法建立人结直肠癌(CRC)裸鼠移植瘤模型并随机分为3组,瘤块内分别注射 APRIL siRNA、空载体和 PBS液。RT-PCR和免疫组织化学法(IHC)检测 A-PRIL水平和蛋白表达,人基质金属蛋白酶抑制因子-3(IHC检测TIMP-3),多配体蛋白聚糖-1(Syndecan-1,又名CD138)和基质金属蛋白酶-9(MMP-9)蛋白表达。结果①注射PBS组裸鼠移植瘤瘤块质量(2.15±0.30 g)明显高于注射 APRIL siRNA组(0.95±0.15 g,P<0.05),与注射空载体组(2.20±0.25 g)比较差异无统计学意义(P>0.05)。②注射 PBS组裸鼠 APRIL mRNA/18S rRNA比值(2.48±0.25)明显高于注射 APRIL siRNA组(0.39±0.15,P<0.05),与注射空载体组(2.51±0.30)比较差异无统计学意义(P>0.05)。③注射 APRIL siRNA 明显抑制 SW480细胞侵袭转移,3组 TIMP-3 Allred得分为7.70±0.35,1.10±0.16和1.15±0.12;Syndecan-1蛋白分别为7.80±0.30,1.05±0.20和1.10±0.22;MMP-9蛋白分别为1.20±0.10,8.00±0.25和8.20±0.20。结论 APRIL与人结直肠癌细胞 SW480的生长和转移有密切关系。
Objective To investigate the role of APRIL in SW480 cell line.Methods The CRC model was established in the nude mice,all the mice were divided into 3 groups,the mice were separately treated with APRIL siRNA,pGC-vector and PBS solution.The APRIL mRNA was detected by RT-PCR and the APRIL protein was surveyed by the way of immunohis-tochemistry (IHC).The proteins of TIMP-3,Syndecan-1and MMP-9 also were assessed by IHC.Results ①Tumor mass in the group of nude mice injected with PBS (2.15±0.30 g)was significantly higher than the injection APRIL siRNA group (0.95±0.15 g,P〈0.05),and was not statistically significant (P〉0.05)compared with the injection of empty vector group (2.20±0.25 g).②APRIL mRNA/18S rRNA ratio (2.48±0.25)in the group of mice injected with PBS was signifi-cantly higher than the injection APRIL siRNA group (0.39±0.15,P〈0.05),and was not statistically significant (P〉0.05)compared with the injection of empty vector group (2.51±0.30).③SW480 cells injected with APRIL siRNA signifi-cantly inhibited invasion and metastasis.TIMP-3 Allred scores in three groups were 7.70±0.35,1.10±0.16 and 1.15± 0.12,Syndecan-1 protein was 7.80±0.30,1.05±0.20 and 1.10±0.22 MMP-9 protein was 1.20 ±0.10,8.00±0.25 and 8.20±0.20,respectively.Conlusion APRIL was closely connected with the growth and metabasis of CRC.
出处
《现代检验医学杂志》
CAS
2014年第6期55-58,共4页
Journal of Modern Laboratory Medicine
基金
江苏省“六大人才高峰”资助项目(WS-066).